0001078799 false 12/31 0001078799 2022-02-07 2022-02-07 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  February 4, 2022

 

MARIJUANA COMPANY OF AMERICA, INC.

(Exact Name of Registrant as Specified in Charter) 

 

Utah   000-27039   98-1246221
(State or jurisdiction of   (Commission File   (IRS Employer
incorporation or organization)   Number)   Identification No.) 

  

633 W. 5th Street, Suite 2826

Los Angeles, California ,90071

Telephone: (888) 777-4362

(Address and Telephone Number of Registrant’s Principal
Executive Offices and Principal Place of Business)

 

  

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

    Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425).

 

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12).

 

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)).

 

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).

 

Securities registered pursuant to Section 12(b) of the Act: None.

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

  

Securities registered pursuant to Section 12(g) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock    MCOA   None

 

 

 
 
 

 

Item 3.03 Material Modification to Rights of Security Holders.

(a) On February 4, 2022, the Registrant’s board of directors pursuant to Article IV of its Articles of Incorporation, and Utah Corporations Code 16-10a-1002, unanimously passed a resolution in a special meeting to amend the corporation’s articles to reduce the par value of the Registrant’s common stock from $0.001 per share to zero par value ($0.00) per share.

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

On February 4, 2022, a majority of the Registrant’s shareholders, by written consent without the formality of a meeting, adopted a resolution to amend the Registrant’s articles of incorporation to decrease the par value of its common stock from $0.001 to $0.000 per share. Prior to the amendment, the Company’s common stock had a par value of $0.001.

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits        
 

 

Exhibit

Number

  Description   Location
  3.1  

Written Consent

  Filed Herewith
  20.1   Board Resolution   Filed Herewith
  104   Cover Page Interactive Data File (embedded within the Inline XBRL document).    

 

 

 
 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

MARIJUANA COMPANY OF AMERICA, INC.

 

   
  By:   /s/ Jesus M. Quintero                        
Date: February 8, 2022

Name: Jesus M. Quintero

Title: Chief Executive Officer

 

 

 

Exhibit 3.1

 

 

 

CONSENT OF THE MAJORITY SHAREHOLDERS OF

MARIJUANA COMPANY OF AMERICA, INC.

 

 

The undersigned, constituting a majority of the shareholders eligible to vote of Marijuana Company of America, Inc., a Utah Corporation (the "Company"), hereby adopts the following Written Consents, effective as of February 4, 2022, hereby waiving all notice of, and the holding of, a meeting of the shareholders to act upon such matters and resolutions, pursuant to the Company's By-Laws, and 16-10a-704 of the Utah Corporations Code.

 

WHEREAS, on February 4, 2022, the Company's Board of Directors executed a resolution approving of an amendment to the Company’s Certificate of Incorporation to eliminate the par value of the Company’s common stock, reducing it from $0.001 to $0.00 per share.

 

WHEREAS, the undersigned constitute a majority of the Company's shares eligible to vote on the question, and pursuant to the Company's By-Laws, and Section 16-10a-704 of the Utah corporations code, the majority shareholder may take any action that may be taken at an annual or special meeting of shareholders may without a meeting and without prior notice, if one or more consents in writing, setting forth the action so taken are signed by the holders of outstanding shares having not less than the minimum number of votes that would be necessary to authorize or take the action at a meeting at which all shares entitled to vote on the action were present and voted.;

 

WHEREAS, the undersigned constitute a majority of the shares eligible to vote and have considered and discussed the benefits of amending the Company’s Certificate of Incorporation to eliminate the par value of the Company’s common stock from $0.001 to $0.00 per share.

 

BY MAJORITY CONSENT the undersigned, being a majority of the shareholders eligible to vote of the Company, approves and authorizes amendment to the Company’s Certificate of Incorporation to eliminate the par value of the Company’s common stock from $0.001 to $0.00 per share.

 

CONSENTED FURTHER, that the appropriate Officers of the Company be, and they hereby are, authorized and empowered to execute such documents, take such steps, and perform such acts as, in their judgment, may be necessary or convenient in carrying out the foregoing

 

Written Consent consistent with the Company's By Laws and Utah law, including placing this Written Consent in the appropriate Books and Records of the Company, and that any such documents executed, or acts taken by them shall be conclusive evidence of authority in so doing.

 

IN WITNESS WHEREOF, the undersigned have executed this Written Consent as of date first written above.

 

THE UNDERSIGNED BEING A MAJORITY OF THE SHAREHOLDERS ELIGIBLE TO VOTE OF MARIJUANA COMPANY OF AMERICA, INC.

 

 

Dated: February 4, 2022

 

 

/s/ Jesus Quintero

 

Jesus M. Quintero, beneficial owner of

8,666,666 Class A Preferred Stock (1)

2,000,000 Class B Preferred Stock (2)

 

(1) Each share of Class A Preferred Stock is entitled to 100 votes on all matters submitted to a vote to the stockholders of the Company. Mr. Quintero’s Class A Preferred Stock equates to 866,666,600 voting common shares.

 

(2) The Class B Preferred Stock carries a voting preference of One Thousand (1,000) times that number of votes on all matters submitted to the shareholders that is equal to the number of shares of Common Stock (rounded to the nearest whole number), at the record date for the determination of the shareholders entitled to vote on such matters or, if no such record date is established, at the date such vote is taken or any written consent of such shareholders is affected.

 

Exhibit 20.1

 

 

 

UNANIMOUS CONSENT IN LIEU OF A SPECIAL

MEETING OF DIRECTORS OF

MARIJUANA COMPANY OF AMERICA, INC.

 

 

The undersigned, being all of the directors of Marijuana Company of America, Inc., a corporation of the State of Utah (the “Corporation”), do hereby authorize and approve the actions set forth in the following resolutions without the formality of convening a meeting, and do hereby consent to the following actions of this Corporation, which actions are hereby deemed affective as of the date hereof:

 

RESOLVED: That the Corporation amend its articles of incorporation to change the par value of its common stock from $0.001 to $0.000 per share.

 

RESOLVED FURTHER: That the Board calls for a Special Meeting of the Shareholders to consider and approve the corporate action, or in lieu thereof, obtain the written consent from a majority of the shareholders eligible to vote to approve the corporate action.

 

RESOLVED FURTHER: that each of the officers of the Corporation be, and they hereby are, authorized and empowered to execute and deliver such documents, instruments and papers and to take any and all other action as they or any of them may deem necessary or appropriate of the purpose of carrying out the intent of the foregoing resolutions and the transactions contemplated thereby; and that the authority of such officers to execute and deliver any such documents, instruments and papers and to take any such other action shall be conclusively evidenced by their execution and delivery thereof or their taking thereof.

 

The undersigned, by affixing their signatures hereto, do hereby consent to, authorize, and approve the foregoing actions in their capacity as all of the directors of Marijuana Company of America, Inc.

 

 

Dated: February 4, 2022

 

 

/s/Jesus Quintero   /s/ Edward Manolos

Jesus M. Quintero, Director

Chairman of the Board

  Edward Manolos, Director
     
/s/ Marco Guerrero   /s/ Tad Mailander
Marco Guerrero, Director   Tad Mailander, Director